Similar Papers

Paper Title
Journal
Date
Author
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire
Mauricette Michallet ... Didier Blaise
Experimental Hematology | VOL. 36
Mauricette Michallet, et. al.Mauricette Michallet ... Didier Blaise
17 Mar 2008
Fludarabine/Busulfan Plus Low Dose TBI As Reduced Intensity Conditioning in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Myeloid Malignancies
Manar Mohamed Ibrahim Khalil ... Fotios V Michelis
Blood | VOL. 128
Manar Mohamed Ibrahim Khalil, et. al.Manar Mohamed Ibrahim Khalil ... Fotios V Michelis
02 Dec 2016
Improved Outcomes Using Tacrolimus/Sirolimus for Graft-versus-Host Disease Prophylaxis with a Reduced-Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant as treatment of Myelofibrosis
David S Snyder ... Stephen J Forman
Biology of Blood and Marrow Transplantation | VOL. 16
David S Snyder, et. al.David S Snyder ... Stephen J Forman
26 Sep 2009
Impact of Low-Dose TBI on Outcome of Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation from HLA Identical Sibling for Acute Myeloid Leukemia
Jun Aoki ... Akiyoshi Takami
Blood | VOL. 124
Jun Aoki, et. al.Jun Aoki ... Akiyoshi Takami
06 Dec 2014
View more papers

More From: American journal of hematology

Paper Title
Journal
Date
Author
Clinico-Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response and Outcomes toContemporary Therapies.
Jayastu Senapati ... Courtney D Dinardo
American journal of hematology | VOL. -
Jayastu Senapati, et. al.Jayastu Senapati ... Courtney D Dinardo
08 Feb 2025
It's More Than Complex: Further Insights Into TP53 in MPN.
Nico Gagelmann ... Nicolaus Kröger
American journal of hematology | VOL. -
Nico Gagelmann, et. al.Nico Gagelmann ... Nicolaus Kröger
08 Feb 2025
Issue Information
-
American Journal of Hematology | VOL. -
--
07 Feb 2025
Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort Study.
Samuel Yamshon ... Loretta J Nastoupil
American journal of hematology | VOL. -
Samuel Yamshon, et. al.Samuel Yamshon ... Loretta J Nastoupil
07 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.